SCHEMBL6079154

SCHEMBL6079154

NC(=O)[C@@H]1CCCN1Cc1cc(C(F)(F)F)ccc1-n1cnnn1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.50
KCNH2 Q12809 4/20 0.41
GPR119 Q8TDV5 4/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
DPP4 P27487 1/20 0.39
NOTUM Q6P988 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
DDR1 Q08345 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6077990 0.99 SCN9A (0.49) SCN9AKCNH2GPR119POLBALDH1A1
SCHEMBL6077686 0.87 MAOA (0.45) POLBLMNACYP3A4CYP2C9CYP2C19
SCHEMBL6078656 0.85 F2 (0.47) POLBALDH1A1LMNACYP3A4DDR1
Hydrochloric Acid SCHEMBL6079141 0.84 F2 (0.46) POLBALDH1A1LMNACYP3A4DDR1
SCHEMBL6079360 0.83 POLB (0.51) POLBSMN1; SMN2LMNACYP1A2CYP2C19
SCHEMBL6077923 0.82 PTGER4 (0.38) SCN9AKCNH2GPR119ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL6078937 0.82 POLB (0.50) POLBSMN1; SMN2LMNACYP1A2CYP2C19
SCHEMBL6079352 0.77 F2 (0.46) ALDH1A1LMNACYP3A4CYP2C9CYP2C19
SCHEMBL6078292 0.76 SCN9A (0.37) SCN9AKCNH2GPR119ALDH1A1KDM4E
SCHEMBL20791371 0.73 ALDH1A1 (0.63) SCN9AALDH1A1KDM4ESMN1; SMN2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144899-B2 Thrombin inhibitors MERCK & CO., INC. (US) 2006-12-05 US disclosed
US-20040073025-A1 Thrombin inhibitors MERCK SHARP & DOHME CORP. 2004-04-15 US disclosed
WO-2002064559-A2 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073025-A1 Thrombin inhibitors F2, F11, F10 SCN9A 1729/4885KCNH2 1427/4885GPR119 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.